CLINICAL CHEMISTRY LACTATE DEHYDROGENASE 02P56-21

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2017-05-05 for CLINICAL CHEMISTRY LACTATE DEHYDROGENASE 02P56-21 manufactured by Abbott Manufacturing Inc.

Event Text Entries

[74596944] A review of complaint tracking and trending metrics was performed and identified no related adverse or non-statistical trends in conjunction with the complaint issue currently under evaluation for this product. The architect clinical chemistry lactate dehydrogenase reagent assay insert and the architect operations manual contain information to address the current customer issue. As the reagent lot has expired, no testing was performed. Based on the information obtained through this evaluation and the information from the customer site, there is evidence to reasonably suggest that a product malfunction occurred. However, no systemic issue or product deficiency was identified. Lot/serial number was manufactured prior to udi compliance date; therefore, only a di is provided.
Patient Sequence No: 1, Text Type: N, H10


[74596945] The customer reports falsely elevated clin chem ldh assay results being generated on patient samples tested on the architect c8000 analyzer. Controls trend high but still within specifications. Proficiency samples have always passed. The customer uses serum patient samples and always runs samples in a 1:3 dilution. The customer notes that when the samples are retested the following day, values drop significantly into the normal reference range (12% to 47% decrease). When using reagent lot 11911un15, the customer reported the following values (day 1, day 2): sample 1: 277, 243 u/l; sample 2: 336, 189 u/l; sample 3: 679, 536 u/l; sample 4: 171, 149 u/l; and sample 5: 200, 176 u/l. These same types of ranges were seen on a second architect csystem in the lab. The customer uses a normal reference range of 125 - 220 u/l. Some results have been questioned by physicians as being higher than expected. There is no adverse impact to patient management reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1628664-2017-00186
MDR Report Key6549271
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2017-05-05
Date of Report2017-05-05
Date Mfgr Received2017-04-21
Device Manufacturer Date2015-08-10
Date Added to Maude2017-05-05
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT MANUFACTURING INC
Manufacturer Street1921 HURD DRIVE
Manufacturer CityIRVING TX 75038
Manufacturer CountryUS
Manufacturer Postal Code75038
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCLINICAL CHEMISTRY LACTATE DEHYDROGENASE
Generic NameLACTATE DEHYDROGENASE
Product CodeCFJ
Date Received2017-05-05
Catalog Number02P56-21
Lot Number11911UN15
Device Expiration Date2016-05-14
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT MANUFACTURING INC
Manufacturer Address1921 HURD DRIVE IRVING TX 75038 US 75038


Patients

Patient NumberTreatmentOutcomeDate
10 2017-05-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.